Ipsen S.A. publishes its 2023 Consolidated Financial Statements
Ipsen S.A. – 2023 Consolidated Financial Statements
Attachment
14 October 2024
1 mins read
Excellence in action: Ipsen is first pharma company to receive two Gold Shingo Prizes
29 June 2022
1 mins read
Ipsen announces U.S. FDA Priority Review for palovarotene New Drug Application in patients with fibrodysplasia ossificans progressiva following resubmission
01 June 2021
1 mins read
Ipsen announces the launch of an Employee Shareholding Plan